Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

NewAmsterdam Pharma Co N.V.

Pharmaceutical Preparations · Narrden, Netherlands

  1. PrincipalsJohannes Jacob Pieter KasteleinChief Scientific OfficerLouise Frederika KooijChief Accounting OfficerMayur Ian SomaiyaChief Financial Officerand 7 more
  2. CompanyNewAmsterdam Pharma Co N.V.Narrden, Netherlands
  3. Phone line+31 35 206 2971General business
Request a quote

NewAmsterdam Pharma Co N.V. is an SEC-registered Nasdaq-listed company (ticker NAMS) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 10

Chief executive

Michael H. DavidsonChief Executive Officer

Chair & board

Adele M. GulfoDirector (Board)
John W SmitherDirector (Board)
Louis G LangeDirector (Board)
Mark C. McKennaDirector (Board)

Finance

Louise Frederika KooijChief Accounting Officer
Mayur Ian SomaiyaChief Financial Officer
Everyone else on file (1)
Johannes Jacob Pieter KasteleinChief Scientific Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Michael H. Davidson — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Johannes Jacob Pieter Kastelein — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Louise Frederika Kooij — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Mayur Ian Somaiya — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers